<PAGE>
 
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A

                          AMENDMENT TO QUARTERLY REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED MARCH 31, 1997          COMMISSION FILE NUMBER 0-19749

                              CHEMTRAK INCORPORATED
             (Exact name of Registrant as specified in its charter)

            DELAWARE                                      77-0295388
  (State or other jurisdiction of              (IRS Employer Identification No.)
  incorporation or organization)

                   929 EAST ARQUES AVENUE, SUNNYVALE, CA 94086
          (Address of principal executive offices, including zip code)

                                 (408) 773-8156
              (Registrant's telephone number, including area code)

        Securities registered pursuant to Section 12(b) of the Act: NONE

           Securities registered pursuant to Section 12(g) of the Act:
                          COMMON STOCK, $.001 PAR VALUE

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities and Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [x] No [ ]

         The number of shares of Common Stock outstanding as of July 7, 1997 was
12,926,443.

================================================================================
<PAGE>
                                    PART II

Item 6. Exhibits

(a)
        10.39**  Distribution Agreement between ChemTrak and Helena Laboratories
                 (Canada) Ltd. dated February 27, 1997.


___________________
** Confidential treatment has been requested for portions of this document.


                                       8.
<PAGE>
 
                                   SIGNATURES

    
         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.      

                                        CHEMTRAK INCORPORATED


                                            
                                        By: /s/ Donald V. Fluken
                                           -------------------------------------
                                               Donald V. Fluken
                                               Chief Financial Officer
                                               (Principal Financial and 
                                               Accounting Officer)     

    
                                        Date:      May 21, 1998
                                             ________________________________
     


                                      9. 

<PAGE>
 
                               INDEX TO EXHIBITS


Exhibit No.     Description
-----------     -----------
 10.39**        Distribution Agreement between ChemTrak and Helena Laboratories 
                (Canada) Ltd. dated February 27, 1997.


___________
** Confidential treatment has been requested for portions of this document.